Oxalic Acid

Oxalic Acid

SCHEMBL4496330

CCCN(CCC)C(=O)c1ccc(OCCCN2CC3CCCC3C2)cc1.O=C(O)C(=O)O

nearest known ligand 0.62

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

OPRM1SLC6A4

The experimentally established mechanism targets of Oxalic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 8/20 0.62
KDM4E B2RXH2 8/20 0.49
ALDH1A1 P00352 6/20 0.47
LMNA P02545 1/20 0.47
MEN1 O00255 1/20 0.46
HTT P42858 1/20 0.46
KMT2A Q03164 1/20 0.46
POLB P06746 1/20 0.46
MAPT P10636 1/20 0.46
HRH2 P25021 1/20 0.45
HRH1 P35367 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4621699 0.97 HRH3 (0.66) HRH3HRH2HRH1
Oxalic Acid SCHEMBL4506377 0.92 HRH3 (0.65) HRH3KDM4EALDH1A1LMNAMEN1
Oxalic Acid SCHEMBL4501979 0.91 HRH3 (0.61) HRH3KDM4EALDH1A1LMNAMEN1
SCHEMBL4620858 0.88 HRH3 (0.69) HRH3KDM4EALDH1A1LMNAMAPT
SCHEMBL4619663 0.87 HRH3 (0.65) HRH3HRH2HRH1
Oxalic Acid SCHEMBL4485952 0.87 HRH3 (0.67) HRH3KDM4EALDH1A1MEN1HTT
Oxalic Acid SCHEMBL4504804 0.86 HRH3 (0.64) HRH3KDM4EALDH1A1MEN1HTT
Oxalic Acid SCHEMBL4493353 0.84 HRH3 (0.61) HRH3KDM4EALDH1A1MEN1HTT
Oxalic Acid SCHEMBL4490857 0.84 HRH3 (0.66) HRH3KDM4EALDH1A1MEN1HTT
Oxalic Acid SCHEMBL4496673 0.84 HRH3 (0.66) HRH3KDM4EALDH1A1MEN1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7576120-B2 Azabicyclic compounds, a process for their preparation and pharmaceutical compositions containing them LES LABORATOIRES SERVIER (FR) 2009-08-18 US disclosed
US-20070197625-A1 Azabicyclic compounds, a process for their preparation and pharmaceutical compositions containing them. LES LABORATORATIES SERVIER (FR) 2007-08-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070197625-A1 Azabicyclic compounds, a process for their preparation and pharmaceutical compositions containing them. HRH2, HNMT, HRH1 HRH3 9/4885KDM4E 461/4885ALDH1A1 308/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.